Rewind Therapeutics
BelgiumWho owns Rewind Therapeutics?
Rewind Therapeutics is a Belgian Biotech company, currently owned by Sunstone Life Science Ventures since 2023 and Boehringer Ingelheim Venture Fund.
Hand-verified · updated 2026-07-03
Open JSON · CC-BYKey facts
Ownership history
2 ownership periods · co-invest detected
More from Sunstone Life Science Ventures V
Other portfolio companies in the same fund.
Italy
France
Netherlands
Denmark
GermanyMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Rewind Therapeutics?
Rewind Therapeutics is currently owned by Sunstone Life Science Ventures and Boehringer Ingelheim Venture Fund, through Sunstone Life Science Ventures V, since 2023.
When did Sunstone Life Science Ventures and 1 other acquire Rewind Therapeutics?
Sunstone Life Science Ventures and 1 other acquired Rewind Therapeutics in 2023.
Who has owned Rewind Therapeutics over time?
Rewind Therapeutics has been through 2 private-equity ownership periods: Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2017; Sunstone Life Science Ventures · via Sunstone Life Science Ventures V · since 2023.